CME Symposium Information

Return to Main Meeting Accreditation Page

Return to Meeting Access Page 


CME Symposium
Bridging the Gap in the Diagnosis and Management of Postmenopausal Osteoporosis: Challenges and Advances


February, 26, 2021 | 11:30 AM - 12:30 PM |CMHC Masterclass | Eastern Time


This activity is supported by educational funding provided by Amgen.


Endocrinologists, obstetricians, gynecologists, midwives, diabetologists, primary care physicians, cardiologists, lipidologists, and as well as nurses, nurse practitioners, and pharmacists.


Osteoporosis is a prevalent condition and a major health problem, but particularly more in postmenopausal women.  Approximately 2 million osteoporosis-related fractures occur annually in the US, and more than 70% of these occur in women.  Furthermore, osteoporosis carries a significant burden, estimated to be at $57 billion in 2018 and projected to reach more than $95 billion by year 2040.

Despite these impacts, postmenopausal osteoporosis remains underdiagnosed and undertreated.  New guidelines that incorporate all the available treatment options have been recently published, however, diagnosis and treatment gaps may persist, as questions remain about the risk assessment, diagnostic interpretation, as well as therapy selection, monitoring, and appropriate switching or tapering off.  During this symposium, multi-disciplinary experts will overview the updates in postmenopausal osteoporosis screening, diagnosis and management, as well as the individualization of treatment in this setting.


After completing this activity, the participant should be better able to:

  • Summarize recent advances in the screening and diagnostic approaches for postmenopausal osteoporosis.
  • Review recent guideline updates for the management of postmenopausal osteoporosis.
  • Develop individualized treatment regimens to reduce the risk of fracture and minimize bone density decline in postmenopausal women with osteoporosis based on updated guidelines, available treatment options, and patient-specific risk factors.


Pam Taub, MD, FACC (Chair)

  • Associate Professor of Medicine
  • Director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
  • UC San Diego Health System
  • Division of Cardiovascular Medicine
  • La Jolla, CA

Kathryn Macaulay, MD

  • Director, UCSD Menopause Health Program
  • Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences
  • UC San Diego Health

Rachel Pessah-Pollack, MD, FACE

  • Clinical Associate Professor of Medicine
  • Department of Endocrinology, Diabetes & Metabolism
  • NYU Langone Health
  • New York, NY



In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMHC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

This is an application-based activity. Universal Activity Numbers (UAN) JA4008162-9999-21-2605-L01-P.

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.


The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.


This program offers 1.0 CPEUs for dieticians.


Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


A full listing of faculty disclosures will be provided here.

Planners and Managers

The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


In order to access the evaluations you must first REGISTER or login on this website. Please note this is a separate site from
. To begin registration steps:

  1. Click here to register or login now and follow the instructions
  2. Once registered and logged in, return and register for the evaluations.  Thank you.
Evaluation TypeCredits AvailableEvaluation Link
(available starting Feb 26 12:00 PM EST)
General SessionsLearners may earn up to a maximum of 6.25 AMA/ACPE/ANCC/CDR credits. General Sessions CME information can be found here.Access General Session Evaluation
CME SymposiumAn additional 1.0 credit hour may be earned for attending the midday CME Symposium. Symposium CME information can be found here.Access CME Symposium Evaluation

PLEASE NOTE: Evaluations must be completed by Monday, March 8.  

For questions regarding the evaluation, please contact 


There is no registration fee for participating and receiving CME/CE credit for this educational activity.

Return to Main Meeting Accreditation Page

Return to Meeting Access Page